‹ All questions

Centene vs Molina Healthcare: which stock is doing better?

Centene and Molina Healthcare are business rivals. Where they compete: medicaid and ACA marketplace managed care; near-pure-play overlap across Centene's two largest segments. Here is how the two stocks, and the businesses behind them, compare over the past year.

Updated Oct 9, 2026

81
CNC P3

CNC ahead

On Stox’s P3 score, which combines market beat, staying power and business growth, Centene rates 81 and Molina Healthcare 24. Over the past year Centene is +70% and Molina Healthcare −3%, against +16% for the S&P 500. Centene has grown revenue faster, +17% against +8%. Centene swings less, about 3.8% on a typical day against 4.3%. By type, Centene is a Distribution Top and Molina Healthcare a Sleepy Staple.

CNC P3 81MOH P3 24Both in Aerospace-defense

The past year

CNC against MOH, each set to $100 a year ago. Select a measure in the table below to chart it for both.

CNC against MOH, past year
$100 a year ago. CNC +70%, MOH −3%.
100150NovDecJanFebMarAprMayJunJulAugSepOct
CNCMOH

CNC and MOH side by side

Ahead marks the stronger reading on each line; for the typical day and the deepest fall it marks the steadier stock. Select a row with a chart to see both over the year.

MeasureCNCMOHAhead
Past 3 months
Share price change
−4%−19%CNC
Past month
Share price change
−0%−2%CNC
Revenue growth
Past four quarters against the year before
+17%+8%CNC
Operating margin
Operating profit as a share of revenue, past four quarters
-4%1%MOH
Deepest fall
From a high, past year
−33%−40%CNC, held up
Market value
What the market values the company at
$32.3B$10.3B
Type
Its Stox Atlas type
Distribution TopSleepy Staple
Group
Stocks it moves with
Aerospace-defenseAerospace-defenseSame group

How to read this page

How it’s measured. Scores from Stox rank each stock against about 1,200 large US stocks and funds, where 100 is best; P3 combines market beat, staying power and business growth. Returns are share-price changes. The typical day is the average true range over 14 days as a share of the price, averaged over the past year.

Sources. Daily prices and company financial statements from Financial Modeling Prep; scores and curated rivals from Stox.

A higher score describes a stronger past year, not what comes next.

Rivals are chosen by the markets the two businesses compete in, not by sector labels.

For financial statements, valuation and news, see CNC and MOH on Stox.

This page is information, not investment advice. About our data and methods ›

More head-to-heads

See all questions ›